USP20 promotes pancreatic cancer cell proliferation and migration by stabilizing TWIST
Article
Figures
Metrics
Preview PDF
Reference
Related
Cited by
Materials
Abstract:
[Abstract] Objective: To investigate the expression of ubiquitin-specific protease 20 (USP20) in pancreatic cancer tissues and its role and molecular mechanism in the proliferation and migration of pancreatic cancer cells. Methods: The Cancer Genome Atlas (TCGA) database was used to analyze USP20 and TWIST family bHLH transcription factor (TWIST) expression in pancreatic cancer tissues. Kaplan-Meier curve analysis was used evaluate their correlation with patient prognosis. Normal pancreatic cells (HPNE) and pancreatic cancer cells (MIAPaca2, BxPC3, PANC1, SW1990, Aspc1) were routinely cultured, and USP20 protein expression was detected by Western blot (WB). PANC1 and SW1990 cells were divided into shNC, shUSP20-1, and shUSP20-2 groups, and transfected with corresponding lentiviruses. Knockdown efficiency was verified by qPCR and WB. Cell proliferation, migration, and cell cycle distribution were assessed using CCK-8, colony formation, wound healing, Transwell assays, and flow cytometry, respectively. WB was used to detect the expression of epithelial-mesenchymal transition (EMT)-related transcription factors. Co-immunoprecipitation (CoIP) and ubiquitination assays were conducted to determine whether USP20 interacts with TWIST and regulates its expression via the ubiquitination pathway. Results: USP20 and TWIST mRNA levels were significantly upregulated in pancreatic cancer tissues (both P < 0.05), and their levels were negatively correlated with patient prognosis (both P < 0.05). USP20 protein was highly expressed in PANC1, SW1990, MIAPaca2, and BxPC3 cells (all P < 0.001). Knockdown of USP20 significantly inhibited the proliferation and migration of PANC1 and SW1990 cells (all P < 0.001). USP20 interacted with TWIST (P < 0.05 or P < 0.01) and stabilized TWIST expression by reducing its ubiquitination level (P < 0.01). Conclusion: USP20 is highly expressed in pancreatic cancer tissues and promotes pancreatic cancer cell proliferation and migration by stabilizing TWIST through deubiquitination. These findings suggest that USP20 may serve as a potential diagnostic and therapeutic target in the treatment of pancreatic cancer.